Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.
Study Type
OBSERVATIONAL
Enrollment
177
CHU Angers
Angers, France
Clinique Saint Joseph
Angers, France
CHU Brest
Brest, France
CHU Caen
Caen, France
Hôpital Prive Saint Martin
Caen, France
CH Chartres
Chartres, France
CH Laval
Laval, France
CH Le Mans
Le Mans, France
CH Bretagne Sud
Lorient, France
CHU Nantes
Nantes, France
...and 15 more locations
IABP insertion rate
Time frame: 1 year
Number of cardiogenic shock
IABP indications
Time frame: 1 year
Number of mechanical complication of acute coronary syndrome
IABP indications
Time frame: 1 year
Number of myocardial infarction not shocked
IABP indications
Time frame: 1 year
Number of other indications
IABP indications
Time frame: 1 year
Survival rate following IABP insertion
Time frame: 1 year
IABP-related complications rate and type
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.